SEARCH

SEARCH BY CITATION

References

  • 1
    Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547553.
  • 2
    Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987–1990. Obstet Gynecol 1996; 88: 161167.
  • 3
    Ibison JM, Swerdlow AJ, Head JA, Marmot M. Maternal mortality in England and Wales 1970–1985: an analysis by country of birth. Br J Obstet Gynaecol 1996; 103: 973980.
  • 4
    Conde-Agudelo A, Kafury-Goeta AC. Epidemiology of eclampsia in Colombia. Int J Gynecol Obstet 1998; 61: 18.
  • 5
    World Health Organization. The World Health Report 1998. Life in the 21st Century: A Vision For All. Geneva : WHO, 1998: 97.
  • 6
    Pan American Health Organization. Health in the Americas. PAHO Scientific Publication No. 569. Washington DC : PAHO, 1998; II: 210220.
  • 7
    World Health Organization. The Hypertensive Disorders of Pregnancy. Report of a WHO Study Group. World Health Organization Technical Report Series 758. Geneva : WHO, 1987; 6369.
  • 8
    van Beek E, Peeters LLH. Pathogenesis of preeclampsia: a comprehensive model. Obstet Gynecol Surv 1998; 53: 233239.
  • 9
    Schwarcz R, Diaz AG, Fescina R, Diaz JL, Martell M, Simini F. The perinatal information system I: the simplified perinatal clinical record. The perinatal information system I: the simplified perinatal clinical record 1987; 15 (Suppl 1): 9.
  • 10
    Diaz AG, Schwarcz, Diaz-Rosello JL et al. Perinatal Information System. CLAP Scientific Publication 1203.02. Montevideo : CLAP, PAHO/WHO, 1993: 2939.
  • 11
    Diaz-Rosello JL. Health services research, outcomes, and perinatal information systems. Curr Opin Pediatr 1998; 10: 117122.
  • 12
    English version of International Classification of Diseases (10th revised edition). Geneva : World Health Organisation, 1992.
  • 13
    Davey DA, MacGillivray I. The classification and definitions of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892898.
  • 14
    Nutrition during pregnancy and lactation. An implementation guide. Washington , DC : Institute of Medicine, National Academy of Sciences, National Academy Press, 1992.
  • 15
    Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contribution to risk of pre-eclampsia: population based study. BMJ 1998; 316: 13431347.
  • 16
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 1322.
  • 17
    Davies AM. Geographical Epidemiology of the Toxaemias of Pregnancy. Chicago : CC Thomas, 1971.
  • 18
    MacGillivray I. Pre-eclampsia. The Hypertensive Disease of Pregnancy. London : WB Saunders, 1983: 2355.
  • 19
    Vinatier D, Monnier JC. Pre-eclampsia: physiology and immunological aspects. Eur J Obstet Gynecol Reprod Biol 1995; 61: 8597.
  • 20
    Lehmann K. Eklampsien i Danmark i Aarene 1918–1927. Copenhagen : Busck, 1933.
  • 21
    Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of pre-eclampsia and eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 1990; 163: 460465.
  • 22
    Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol 1983; 61: 210216.
  • 23
    Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for pre-eclampsia. JAMA 1991; 266: 237241.
  • 24
    Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. The relationship between induced abortion and outcome of subsequent pregnancies. Am J Obstet Gynecol 1983; 146: 136140.
  • 25
    Spinillo A, Capuzzo E, Egbe TO, Nicola S, Piazzi G, Baltaro F. Cigarette smoking in pregnancy and risk of pre-eclampsia. J Hum Hypertens 1994; 8: 771775.
  • 26
    Parazzini F, Bortolus R, Chatenoud L et al. Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. Epidemiology 1996; 7: 306308.
  • 27
    Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol 1998; 92: 174178.
  • 28
    Campbell DM, Mac Gillivray I. Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 1985; 92: 131140.
  • 29
    Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preclampsia. Obstet Gynecol 1994; 83: 357361.
  • 30
    Salonen Ros H, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998; 147: 10621070.
  • 31
    McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996; 103: 123129.
  • 32
    Neerhof MG. Pregnancy in the chronically hypertensive patient. Clin Perinatol 1997; 24: 391406.
  • 33
    McMahon MJ, Ananth CV, Liston RM. Gestational diabetes mellitus. Risk factors, obstetric complications and infant outcomes. J Reprod Med 1998; 43: 372378.
  • 34
    Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16: 4146.
  • 35
    Berkowitz KM. Insulin resistance and preeclampsia. Clin Perinatol 1998; 25: 873885.
  • 36
    Roberts R. Hypertension in women with gestational diabetes. Hypertension in women with gestational diabetes 1998; 21 (Suppl 2): B27B32.
  • 37
    Knock GA, McCarthy AL, Lowy C, Poston L. Association of gestational diabetes with abnormal maternal vascular endothelial function. Br J Obstet Gynaecol 1997; 104: 229234.
  • 38
    Scott JS. Pregnancy toxaemia associated with hydrops fetalis, hydatidiform mole and hydramnios. J Obstet Gynaecol Br Emp 1958; 65: 689701.
  • 39
    Long PA. Oats JN. Preeclampsia in twin pregnancy: severity and pathogenesis. Aust NZJ Obstet Gynaecol 1987; 27: 15.
  • 40
    Coonrod DV, Hickok DE, Zhu K, Easterling TR, Daling JR. Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstet Gynecol 1995; 85: 645650.
  • 41
    de Watteville H. Fetal malformation and toxemia. In: HammondJ, BrowneFJ, WolstenholmeGW, editors. Toxemia of Pregnancy, Human and Veterinary, London : Churchill, 1950: 202209.
  • 42
    Nelson TR. A clinical study of pre-eclampsia. J Obstet Gynaecol Br Emp 1955; 62: 4851.
  • 43
    Vesce F, Farina A, Giorgetti M et al. Increased incidence of preeclampsia in pregnancies complicated by fetal malformation. Gynecol Obstet Invest 1997; 44: 107111.
  • 44
    Duffus GM, MacGillivray IM. The incidence of pre-eclamptic toxaemia in smokers and non-smokers. Lancet 1968; 1: 994995.
  • 45
    Cnattingius S, Mills JL, Yuen J, Eriksson O, Salonen H. The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol 1997; 177: 156161.
  • 46
    Ylikorkala O, Makila UM. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obstet Gynecol 1985; 152: 318329.
  • 47
    Madretsma GS, Donze GJ, van Dijk AP, Tak CJ, Wilson JH, Zijlstra FJ. Nicotine inhibits the in vitro production of interleukin 2 and tumor necrosis factor-alpha by human mononuclear cells. Immunopharmacology 1996; 35: 4751.
  • 48
    Sastry BV, Hemontolor ME, Olenick M. Prostaglandin E2 in human placenta: Its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology 1999; 58: 7086.
  • 49
    Srivastava ED, Hallet MB, Rhodes J. Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers. Hum Toxicol 1989; 8: 461463.
  • 50
    Mittendorf R, Lain KY, Williams MA, Walker CK. Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med 1996; 41: 491496.
  • 51
    Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473485.
  • 52
    Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 1997; 46: 963967.
  • 53
    Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 614620.
  • 54
    Marcoux S, Brisson J, Fabia J. The effect of leisure time physical activity on the risk of pre-eclampsia and gestational hypertension. J Epidemiol Commun Health 1989; 43: 147152.
  • 55
    Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparae. Epidemiology 1996; 7: 240244.
  • 56
    Robillard PY, Hulsey TC, Perianin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344: 973975.
  • 57
    Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32: 303311.
  • 58
    Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316: 13431347.
  • 59
    Cobo E. Aplicacion de un modelo de historia clinica perinatal. Rev Col Obstet Ginecol 1985; 36: 7994.
  • 60
    Hauth JC, Goldenberg RL, Parker CR Jr et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993; 168: 10831091.
  • 61
    Zhang J, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 1997; 19: 218232.